Lexicon Pharmaceuticals (LXRX) Gross Profit (2016 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Gross Profit of $21.0 million for Q1 2026, up 1604.06% year-over-year from $1.2 million in Q1 2025, and up 296.71% quarter-over-quarter from $5.3 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Gross Profit (2016 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Gross Profit for 10 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 1604.06% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $69.3 million (up 126.46% YoY), while the FY2025 annual figure was $49.5 million, up 62.58% from the prior year.
- Gross Profit improved to $21.0 million in Q1 2026 per LXRX's latest filing, from $5.3 million in the prior quarter.
- Across five years, Gross Profit topped out at $28.8 million in Q2 2025 and bottomed at $35000.0 in Q2 2022.
- Historically, Gross Profit has averaged $7.9 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2024 — Gross Profit soared 3665.23% — and 2025, when it plunged 79.81%.
- Lexicon Pharmaceuticals' Gross Profit stood at $35000.0 in 2022, then surged by 1888.57% to $696000.0 in 2023, then jumped by 3665.23% to $26.2 million in 2024, then slumped by 79.81% to $5.3 million in 2025, then surged by 296.71% to $21.0 million in 2026.
- Business Quant data shows LXRX's Gross Profit at $21.0 million in Q1 2026, $5.3 million in Q4 2025, and $14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 653,000.00 |
| Jun 30, 2026 | 653,000.00 |
| Mar 31, 2026 | 20.99 Mn |
| Mar 31, 2026 | 20.99 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 14.17 Mn |
| Sep 30, 2025 | 14.17 Mn |
| Jun 30, 2025 | 28.83 Mn |
| Jun 30, 2025 | 28.83 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 26.21 Mn |
| Dec 31, 2024 | 26.21 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |